XOMA Royalty Corporation financials

XOMA CIK 0000791908

Source: EDGAR filings · Built 2026-06-02T04:26:41Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Free Cash Flow -13.77M -18.18M -28.13M 10.07M
EBITDA 12.44M
Working Capital 82.44M 101.23M 149.81M 54.44M 84.01M 75.76M
Net Debt 48.67M 17.52M -28.83M -57.79M -93.10M -62.96M
Operating Margin 109.99% -601.14% -1579.17% -419.61% 48.00% 44.44%
Net Margin 306.40% -207.83% -1540.79% -412.14% 43.26% 47.59%
Return on Equity (ROE) 37.78% -22.33% -46.02% -13.79% 11.14% 15.39%
Return on Assets (ROA) 11.63% -6.25% -17.43% -12.18% 9.48% 10.61%
Current Ratio 3.37× 5.15× 8.68× 8.98× 7.48× 7.16×
Debt-to-Equity 1.57× 1.93× 1.40× 0.00× 0.00× 0.25×
Effective Tax Rate 0.32% 29.05% 0.00% 0.09% 0.57% -12.72%
Cash Conversion Ratio 0.09× 0.99× 0.44× 0.75× 1.44× 0.76×
Accruals Ratio 0.11× -0.00× -0.10× -0.03× -0.04× 0.03×
SBC % of Revenue 89.59% 155.07% 343.36% 86.94% 16.96% 14.18%
CapEx Coverage -687.40× -1068.12× -0.84× 388.15×
Free Cash Flow Per Share $-1.18 $-1.58 $-2464.38 $0.88

Valuation Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
P/E Trailing (Diluted) 18.21× 32.08× 56.58×
P/FCF 50.43×
FCF Yield 1.98%
EV / EBITDA 34.78×
P/S 30.47× 47.23× 80.25× 50.78× 6.46× 17.73×
P/B 3.76× 5.07× 2.40× 1.70× 1.66× 5.73×

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenue from Contract with Customer, Excluding Assessed Tax 10.35M 6.65M 2.65M 4.15M 36.52M 27.94M
Revenues 52.15M 28.49M 4.76M 6.03M 38.16M 29.39M
Research and Development Expense 1.71M 2.88M 143.00K 153.00K 171.00K 170.00K
Operating Expenses 40.77M 68.46M 46.61M 23.44M 20.63M 16.97M
Operating Income (Loss) 11.38M -39.98M -41.85M -17.41M 17.53M 12.42M
Income Tax Expense (Benefit) 103.00K -5.66M 0 -15.00K 91.00K -1.50M
Net Income (Loss) Attributable to Parent 31.71M -13.82M -40.83M -17.10M 15.80M 13.30M
Earnings Per Share, Basic $1.53 $-1.65 $-4.04 $-1.98 $0.69 $0.82
Weighted Average Number of Shares Outstanding, Basic 12.08M 11.70M 11.47M 11,413 11.29M 10.67M
Earnings Per Share, Diluted $1.46 $-1.65 $-4.04 $-1.98 $0.65 $0.78
Weighted Average Number of Shares Outstanding, Diluted 17.98M 11.70M 11.47M 11,413 12.19M 11.50M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 82.91M 101.65M 153.29M 57.83M 93.33M
Assets, Current 117.26M 125.60M 169.31M 61.25M 96.97M 88.06M
Assets 272.70M 221.28M 234.30M 140.38M 166.56M 125.28M
Long-term Debt 0 20.85M
Liabilities, Current 34.82M 24.37M 19.50M 6.82M 12.97M 12.30M
Long-term Debt, Excluding Current Maturities 96.45M 106.88M 118.52M 12.76M
Liabilities 168.74M 139.36M 145.58M 16.37M 24.69M 38.86M
Stockholders' Equity Attributable to Parent 83.94M 61.90M 88.72M 124.01M 141.88M 86.42M
Common Stock, Shares, Outstanding 11.86M 11.95M 11.50M 11.45M 11.32M 11.23M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities 2.87M -13.75M -18.16M -12.88M 22.68M 10.09M
Payments to Acquire Property, Plant, and Equipment 20.00K 17.00K 9.00K
Net Cash Provided by (Used in) Investing Activities 50.89M -28.26M -711.00K -20.22M -26.50M -209.00K
Payments for Repurchase of Common Stock 16.04M 13.00K
Payments of Dividends 5.47M 5.47M 5.47M 5.47M 3.50M
Net Cash Provided by (Used in) Financing Activities -26.46M -11.13M 120.59M -4.45M 12.84M 19.79M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (XOMA CIK 0000791908), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

ORMP

ORAMED PHARMACEUTICALS INC.

ABM

ABM INDUSTRIES INCORPORATED

FDMT

4D Molecular Therapeutics, Inc.